Michael Fleischer

827 total citations
26 papers, 495 citations indexed

About

Michael Fleischer is a scholar working on Neurology, Genetics and Epidemiology. According to data from OpenAlex, Michael Fleischer has authored 26 papers receiving a total of 495 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Neurology, 5 papers in Genetics and 5 papers in Epidemiology. Recurrent topics in Michael Fleischer's work include Long-Term Effects of COVID-19 (5 papers), Neuroinflammation and Neurodegeneration Mechanisms (4 papers) and Peripheral Neuropathies and Disorders (3 papers). Michael Fleischer is often cited by papers focused on Long-Term Effects of COVID-19 (5 papers), Neuroinflammation and Neurodegeneration Mechanisms (4 papers) and Peripheral Neuropathies and Disorders (3 papers). Michael Fleischer collaborates with scholars based in Germany, United States and Austria. Michael Fleischer's co-authors include Christoph Kleinschnitz, Andreas Hinz, Andrea Bosse‐Henck, Elmar Brähler, Hubert Wirtz, Carsten Schmuck, Mark Stettner, Anne K. Mausberg, Gerd Meyer zu Hörste and Fabian Szepanowski and has published in prestigious journals such as SHILAP Revista de lepidopterología, Immunity and Chemical Communications.

In The Last Decade

Michael Fleischer

25 papers receiving 488 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Fleischer Germany 13 147 105 89 79 79 26 495
Çağrı Mesut Temuçin Türkiye 15 186 1.3× 88 0.8× 123 1.4× 31 0.4× 106 1.3× 66 595
Alessandra Mandelli Italy 15 162 1.1× 294 2.8× 63 0.7× 24 0.3× 64 0.8× 32 775
Arianna Sartori Italy 14 291 2.0× 75 0.7× 41 0.5× 22 0.3× 69 0.9× 43 537
Salam Koussa Lebanon 14 127 0.9× 90 0.9× 55 0.6× 20 0.3× 148 1.9× 40 622
Kee Duk Park South Korea 13 132 0.9× 139 1.3× 54 0.6× 24 0.3× 44 0.6× 45 454
Rajesh Kumar Singh India 12 113 0.8× 90 0.9× 62 0.7× 54 0.7× 18 0.2× 49 430
Maria Grazia Egitto Italy 12 102 0.7× 147 1.4× 69 0.8× 33 0.4× 26 0.3× 22 562
Paola Naldi Italy 17 232 1.6× 72 0.7× 71 0.8× 20 0.3× 182 2.3× 41 726
Marek Joukal Czechia 14 154 1.0× 128 1.2× 141 1.6× 40 0.5× 178 2.3× 45 694
Barbara Willekens Belgium 13 140 1.0× 74 0.7× 28 0.3× 14 0.2× 54 0.7× 49 557

Countries citing papers authored by Michael Fleischer

Since Specialization
Citations

This map shows the geographic impact of Michael Fleischer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Fleischer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Fleischer more than expected).

Fields of papers citing papers by Michael Fleischer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Fleischer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Fleischer. The network helps show where Michael Fleischer may publish in the future.

Co-authorship network of co-authors of Michael Fleischer

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Fleischer. A scholar is included among the top collaborators of Michael Fleischer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Fleischer. Michael Fleischer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kwon, Eun‐Hae, et al.. (2022). SARS-CoV-2, COVID-19 and Parkinson’s Disease—Many Issues Need to Be Clarified—A Critical Review. Brain Sciences. 12(4). 456–456. 7 indexed citations
2.
3.
4.
Fleischer, Michael, Tim Hagenacker, Thomas Skripuletz, et al.. (2022). Anti-EBNA1 IgG titre is not associated with fatigue in multiple sclerosis patients. Neurologia i Neurochirurgia Polska. 56(3). 236–245. 2 indexed citations
5.
Fleischer, Michael, Hannah Dinse, Adam Schweda, et al.. (2022). Post-COVID-19 Syndrome is Rarely Associated with Damage of the Nervous System: Findings from a Prospective Observational Cohort Study in 171 Patients. Neurology and Therapy. 11(4). 1637–1657. 33 indexed citations
6.
Fleischer, Michael, Benjamin Stolte, Heike Kölbel, et al.. (2022). Essen transition model for neuromuscular diseases. SHILAP Revista de lepidopterología. 4(1). 41–41. 7 indexed citations
7.
Dzyubenko, Egor, et al.. (2021). Inhibitory control in neuronal networks relies on the extracellular matrix integrity. Cellular and Molecular Life Sciences. 78(14). 5647–5663. 24 indexed citations
8.
Fleischer, Michael, Ioannis N. Petropoulos, Rayaz A. Malik, et al.. (2021). Corneal confocal microscopy differentiates inflammatory from diabetic neuropathy. Journal of Neuroinflammation. 18(1). 89–89. 17 indexed citations
9.
Mizurini, Daniella M., Ivo M.B. Francischetti, Michael Fleischer, et al.. (2021). Elastase inhibitor agaphelin protects from acute ischemic stroke in mice by reducing thrombosis, blood–brain barrier damage, and inflammation. Brain Behavior and Immunity. 93. 288–298. 24 indexed citations
10.
Bolz, Saskia, Michael Fleischer, Elisabeth Livingstone, et al.. (2021). Detect it so you can treat it: A case series and proposed checklist to detect neurotoxicity in checkpoint therapy. eNeurologicalSci. 22. 100324–100324. 15 indexed citations
11.
Pfister, Frederick, Julia Krämer, Ute Eisenberger, et al.. (2021). Autoimmune glomerulonephritis in a multiple sclerosis patient after cladribine treatment. Multiple Sclerosis Journal. 27(12). 1960–1964. 7 indexed citations
12.
Mausberg, Anne K., Gerd Meyer zu Hörste, Michael Fleischer, et al.. (2020). NK cell markers predict the efficacy of IV immunoglobulins in CIDP. Neurology Neuroimmunology & Neuroinflammation. 7(6). 12 indexed citations
13.
Fleischer, Michael, et al.. (2020). Development of a Fully Implantable Stimulator for Deep Brain Stimulation in Mice. Frontiers in Neuroscience. 14. 726–726. 9 indexed citations
14.
Heming, Michael, Xiaolin Li, Saskia Räuber, et al.. (2020). Neurological Manifestations of COVID-19 Feature T Cell Exhaustion and Dedifferentiated Monocytes in Cerebrospinal Fluid. Immunity. 54(1). 164–175.e6. 117 indexed citations
15.
Sánchez-Mendoza, Eduardo H., Luiza Martins Nascentes Melo, Egor Dzyubenko, et al.. (2020). Compromised Hippocampal Neuroplasticity in the Interferon-α and Toll-like Receptor-3 Activation-Induced Mouse Depression Model. Molecular Neurobiology. 57(7). 3171–3182. 15 indexed citations
16.
Thimm, Andreas, Saskia Bolz, Michael Fleischer, et al.. (2019). Prevalence of hereditary transthyretin amyloid polyneuropathy in idiopathic progressive neuropathy in conurban areas. SHILAP Revista de lepidopterología. 1(1). 30–30. 1 indexed citations
17.
Kizina, Kathrin, Benjamin Stolte, Andreas Totzeck, et al.. (2019). Clinical Implication of Dosimetry of Computed Tomography- and Fluoroscopy-Guided Intrathecal Therapy With Nusinersen in Adult Patients With Spinal Muscular Atrophy. Frontiers in Neurology. 10. 1166–1166. 23 indexed citations
18.
Fluri, Felix, Michael Fleischer, & Christoph Kleinschnitz. (2015). Accidental Thrombolysis in a Stroke Patient Receiving Apixaban. Cerebrovascular Diseases Extra. 5(2). 55–56. 5 indexed citations
19.
Fleischer, Michael, Andreas Hinz, Elmar Brähler, Hubert Wirtz, & Andrea Bosse‐Henck. (2013). Factors Associated With Fatigue in Sarcoidosis. Respiratory Care. 59(7). 1086–1094. 39 indexed citations
20.
Hinz, Andreas, Michael Fleischer, Elmar Brähler, Hubert Wirtz, & Andrea Bosse‐Henck. (2011). Fatigue in patients with sarcoidosis, compared with the general population. General Hospital Psychiatry. 33(5). 462–468. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Çağrı Mesut Temuçin Breakdown of academic impact, for papers by Alessandra Mandelli Breakdown of academic impact, for papers by Arianna Sartori Breakdown of academic impact, for papers by Salam Koussa Breakdown of academic impact, for papers by Kee Duk Park Breakdown of academic impact, for papers by Rajesh Kumar Singh Breakdown of academic impact, for papers by Maria Grazia Egitto Breakdown of academic impact, for papers by Paola Naldi Breakdown of academic impact, for papers by Marek Joukal Breakdown of academic impact, for papers by Barbara Willekens
Rankless by CCL
2026